SKN | Lockheed Martin Shares Climb After Strong Q4 Earnings as Defense Demand Fuels Outlook
Lockheed Martin Corporation shares advanced in late January trading after the defense giant reported a strong fourth-quarter performance, underpinned by surging earnings and a...
SKN | Marsh & McLennan Slips Ahead of Earnings as Investors Weigh Valuation and Growth Outlook
Marsh & McLennan Companies, Inc. shares eased modestly in recent trading as investors position ahead of the firm’s upcoming earnings release, balancing steady fundamentals...
SKN | SpyGlass Pharma Sets Terms for $150 Million IPO in Chronic Eye Disease Market Debut
SpyGlass Pharma, a biotech company focused on treatments for chronic eye conditions, has set the terms for a planned $150 million initial public offering,...
SKN | Xsolla SPAC 1 Prices Downsized $200 Million IPO as Gaming-Focused Deal Tests SPAC Appetite
Xsolla SPAC 1, a special purpose acquisition company backed by executives from video game fintech firm Xsolla, has priced a downsized $200 million initial...
SKN | Belgian Fibrotic Disease Biotech AgomAb Therapeutics Sets Terms for $200 Million US IPO
AgomAb Therapeutics, a Belgian biotechnology company developing treatments for fibrotic diseases, has set terms for a planned $200 million initial public offering in the...
